Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Replication-selective adenoviruses as oncolytic agents.

Literature DB >> 10749561

Replication-selective adenoviruses as oncolytic agents.

C Heise¹, D H Kirn.

Abstract

Mesh：

Year: 2000 PMID： 10749561 PMCID： PMC377494 DOI： 10.1172/JCI9762

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

25 in total

1. Cellular targets for transformation by the adenovirus E1A proteins.

Authors: P Whyte; N M Williamson; E Harlow
Journal: Cell Date: 1989-01-13 Impact factor: 41.582

2. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis.

Authors: C Gomez-Manzano; J Fueyo; A P Kyritsis; P A Steck; J A Roth; T J McDonnell; K D Steck; V A Levin; W K Yung
Journal: Cancer Res Date: 1996-02-15 Impact factor: 12.701

3. The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants.

Authors: A E Tollefson; J S Ryerse; A Scaria; T W Hermiston; W S Wold
Journal: Virology Date: 1996-06-01 Impact factor: 3.616

4. Two regions of the adenovirus early region 1A proteins are required for transformation.

Authors: P Whyte; H E Ruley; E Harlow
Journal: J Virol Date: 1988-01 Impact factor: 5.103

5. The properties of p53 proteins selected for the loss of suppression of transformation.

Authors: D C Olson; A J Levine
Journal: Cell Growth Differ Date: 1994-01

6. Cytolysis of adenovirus-infected murine fibroblasts by IFN-gamma-primed macrophages is TNF- and contact-dependent.

Authors: D B Day; N A Zachariades; L R Gooding
Journal: Cell Immunol Date: 1994-08 Impact factor: 4.868

Review 7. Cancer cell cycles.

Authors: C J Sherr
Journal: Science Date: 1996-12-06 Impact factor: 47.728

8. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.

Authors: J R Bischoff; D H Kirn; A Williams; C Heise; S Horn; M Muna; L Ng; J A Nye; A Sampson-Johannes; A Fattaey; F McCormick
Journal: Science Date: 1996-10-18 Impact factor: 47.728

9. Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis.

Authors: J Shisler; P Duerksen-Hughes; T M Hermiston; W S Wold; L R Gooding
Journal: J Virol Date: 1996-01 Impact factor: 5.103

Review 10. Regulation of TNF-mediated cell death and inflammation by human adenoviruses.

Authors: L R Gooding
Journal: Infect Agents Dis Date: 1994 Apr-Jun

34 in total

Review 1. Regulatable systems: applications in gene therapy and replicating viruses.

Authors: S Agha-Mohammadi; M T Lotze
Journal: J Clin Invest Date: 2000-05 Impact factor: 14.808

Review 2. Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer.

Authors: T Hermiston
Journal: J Clin Invest Date: 2000-05 Impact factor: 14.808

Review 3. Immunomodulation of cancer: potential use of selectively replicating agents.

Authors: S Agha-Mohammadi; M T Lotze
Journal: J Clin Invest Date: 2000-05 Impact factor: 14.808

4. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice.

Authors: D Hanahan; G Bergers; E Bergsland
Journal: J Clin Invest Date: 2000-04 Impact factor: 14.808

5. Therapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, Δ24DoubleRGD, in an ovarian cancer model.

Authors: Lena J Gamble; Hideyo Ugai; Minghui Wang; Anton V Borovjagin; Qiana L Matthews
Journal: J Mol Biochem Date: 2012-02-15

10. The targeted inhibitory effects of human amniotic fluid stem cells carrying CXCR4 promoter and DAL-1 on non-small cell lung carcinoma growth.

Authors: L Li; S Li; T Cai; H Wang; X Xie; Z Liu; Y Zhang
Journal: Gene Ther Date: 2015-08-17 Impact factor: 5.250